← FDA Drug Approvals (Drugs@FDA)

INMAZEB

BLA · Biologics License Application · Sponsor: REGENERON PHARMACEUTICALS · Approved 2020-10-14

Drug application

FDA Application #

BLA761169

Application type

Biologics License Application

Brand name

INMAZEB

Generic name

ATOLTIVIMAB, MAFTIVIMAB, AND ODESIVIMAB-EBGN

Active ingredients

ATOLTIVIMAB; ODESIVIMAB; MAFTIVIMAB

Dosage form

SOLUTION

Route

INJECTION

Marketing status

Prescription

Sponsor

REGENERON PHARMACEUTICALS

Manufacturer

Regeneron Pharmaceuticals, Inc.

First approval

2020-10-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown